AIM: The purpose of this study was to translate the National Institutes of Health (NIH)-Diabetes Prevention Program (DPP) into a church-based setting. METHODS: The lifestyle arm of the NIH-DPP was implemented in an African American Baptist church. Church members 18 years or older completed a risk screen during Sunday service followed by fasting glucose (FG) testing at the church during the week. Persons with prediabetes participated in a 16-session DPP conducted over 4 months. Participation rates, height, weight, blood pressure (BP) and FG were followed for 12 months post-intervention. Fifty participants completed the risk screen, 26 were at risk for diabetes, 16 of 26 received FG testing, and 8 had prediabetes (FG = 100- 125 mg/dL). RESULTS: The mean participation rate was 10.4 (65%) sessions. Following the intervention, weight, systolic and diastolic BP, and FG decreased by 7.5 lb (3.6%), 16 mm Hg (11.7%), 12 mm Hg (14.0%), and 5 mg/dL (4.8%), respectively (P < .05). In comparison with baseline, significant reductions were evident at 6 and 12 months postintervention for all endpoints. CONCLUSIONS: This study demonstrated successful translation of the 16-session NIH-DPP into a church-based setting. Future studies should test this intervention in churches of different sizes and denominations.
AIM: The purpose of this study was to translate the National Institutes of Health (NIH)-Diabetes Prevention Program (DPP) into a church-based setting. METHODS: The lifestyle arm of the NIH-DPP was implemented in an African American Baptist church. Church members 18 years or older completed a risk screen during Sunday service followed by fasting glucose (FG) testing at the church during the week. Persons with prediabetes participated in a 16-session DPP conducted over 4 months. Participation rates, height, weight, blood pressure (BP) and FG were followed for 12 months post-intervention. Fifty participants completed the risk screen, 26 were at risk for diabetes, 16 of 26 received FG testing, and 8 had prediabetes (FG = 100- 125 mg/dL). RESULTS: The mean participation rate was 10.4 (65%) sessions. Following the intervention, weight, systolic and diastolic BP, and FG decreased by 7.5 lb (3.6%), 16 mm Hg (11.7%), 12 mm Hg (14.0%), and 5 mg/dL (4.8%), respectively (P < .05). In comparison with baseline, significant reductions were evident at 6 and 12 months postintervention for all endpoints. CONCLUSIONS: This study demonstrated successful translation of the 16-session NIH-DPP into a church-based setting. Future studies should test this intervention in churches of different sizes and denominations.
Authors: Caroline S Blackwell; Kara A Foster; Scott Isom; Jeffrey A Katula; Mara Z Vitolins; Erica L Rosenberger; David C Goff Journal: Contemp Clin Trials Date: 2010-10-23 Impact factor: 2.226
Authors: Karen H Kim Yeary; Carol E Cornell; Page C Moore; C Heath Gauss; T Elaine Prewitt; Jerome Turner Journal: Obesity (Silver Spring) Date: 2020-01-27 Impact factor: 5.002
Authors: Jeffrey A Katula; Mara Z Vitolins; Erica L Rosenberger; Caroline Blackwell; Mark A Espeland; Michael S Lawlor; W Jack Rejeski; David C Goff Journal: Contemp Clin Trials Date: 2009-09-13 Impact factor: 2.226
Authors: Fabio A Almeida; Kimberlee A Pardo; Richard W Seidel; Brenda M Davy; Wen You; Sarah S Wall; Erin Smith; Mark H Greenawald; Paul A Estabrooks Journal: Contemp Clin Trials Date: 2014-06-21 Impact factor: 2.226
Authors: Elizabeth C Rhodes; Eeshwar K Chandrasekar; Shivani A Patel; K M Venkat Narayan; Thomas V Joshua; Lovoria B Williams; Lucy Marion; Mohammed K Ali Journal: Diabetes Res Clin Pract Date: 2018-09-28 Impact factor: 5.602